Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

BACKGROUND AND AIM: Long-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication outside of China. This study aims to assess efficacy, resistance and safety of TDF for up to 240 weeks in Chinese patients with chronic hepatitis B virus (HBV) infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xieer, Gao, Zhiliang, Xie, Qing, Zhang, Jiming, Sheng, Jifang, Cheng, Jun, Chen, Chengwei, Mao, Qing, Zhao, Wei, Ren, Hong, Tan, Deming, Niu, Junqi, Chen, Shijun, Pan, Chen, Tang, Hong, Wang, Hao, Mao, Yimin, Jia, Jidong, Ning, Qin, Xu, Min, Wu, Shanming, Li, Jun, Zhang, Xinxin, Zhang, Wenyan, Xiong, Cui, Hou, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529393/
https://www.ncbi.nlm.nih.gov/pubmed/30977033
http://dx.doi.org/10.1007/s12072-019-09943-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529393/
https://www.ncbi.nlm.nih.gov/pubmed/30977033
http://dx.doi.org/10.1007/s12072-019-09943-6

Ejemplares similares